CA
NUVL icon

Continuum Advisory’s Nuvalent NUVL Stock Holding History

Continuum Advisory’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-28
Closed -$2.12K – 1983
2024
Q2 		$2.12K Buy
28
+3
+12% +$213 ﹤0.01% 1284
2024
Q1 		$1.69K Buy
+25
New +$1.99K ﹤0.01% 1342

Other funds holding NUVL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Continuum Advisory's NUVL Position: Q3 2024 in Review

Continuum Advisory sold out of Nuvalent (NUVL) in Q3 2024, closing a stake of 28 shares — an estimated $2.12K sold.

Continuum Advisory first reported a position in NUVL in Q1 2024 and held it in 2 quarters. The position peaked at $2.12K in Q2 2024. 193 funds tracked by Wall St. Rank hold NUVL as of Q3 2024.

  • Continuum Advisory reported no remaining Nuvalent position as of Q3 2024 after selling out during the quarter.
  • Continuum Advisory sold 28 Nuvalent shares in Q3 2024, an estimated $2.12K.
  • Continuum Advisory first reported a position in Nuvalent in Q1 2024 and held it in 2 quarters.
  • Continuum Advisory's Nuvalent position peaked at $2.12K in Q2 2024.
  • 193 funds tracked by Wall St. Rank held Nuvalent as of Q3 2024.

Based on Continuum Advisory's 13F filing for Q3 2024, filed 15 Nov 2024.